BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 16144857)

  • 1. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis.
    Gritters M; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Scheffer PG; Teerlink T; Schalkwijk CG; Spreeuwenberg M; Nubé MJ
    Nephrol Dial Transplant; 2006 Jan; 21(1):153-9. PubMed ID: 16144857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis-induced degranulation of polymorphonuclear cells: no correlation between membrane markers and degranulation products.
    Grooteman MP; van Tellingen A; van Houte AJ; Bos JC; Schoorl M; van Limbeek J; Nubé MJ
    Nephron; 2000 Jul; 85(3):267-74. PubMed ID: 10867543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
    Gritters M; Borgdorff P; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Tangelder GJ; Nubé MJ
    Nephrol Dial Transplant; 2008 Sep; 23(9):2911-7. PubMed ID: 18364368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.
    Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M
    Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of heparin and dalteparin on oxidative stress during hemodialysis in patients with end-stage renal disease.
    Nassiri AA; Hakemi MS; Soulati M; Marashian M; Rahbar K; Azizi F
    Iran J Kidney Dis; 2009 Jul; 3(3):162-7. PubMed ID: 19617666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients.
    Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Zoga M; Alevyzaki F; Stamatelou K; Frangou E; Savva L; Nicolaou C
    Nephrology (Carlton); 2006 Dec; 11(6):506-9. PubMed ID: 17199788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin dialysis.
    Bos JC; Grooteman MP; van Houte AJ; Schoorl M; van Limbeek J; Nubé MJ
    Nephrol Dial Transplant; 1997 Jul; 12(7):1387-93. PubMed ID: 9249774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
    Wu CC; Chen JS; Wu WM; Liao TN; Chu P; Lin SH; Chuang CH; Lin YF
    Nephrol Dial Transplant; 2005 Jun; 20(6):1134-9. PubMed ID: 15814542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure.
    Tsuruoka S; Kawaguchi A; Nishiki K; Hayasaka T; Fukushima C; Sugimoto K; Saito T; Fujimura A
    Am J Kidney Dis; 2002 Jan; 39(1):127-33. PubMed ID: 11774111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.
    Kitabayashi C; Naruko T; Sugioka K; Yunoki K; Nakagawa M; Inaba M; Ohsawa M; Konishi Y; Imanishi M; Inoue T; Itabe H; Yoshiyama M; Haze K; Becker AE; Ueda M
    Hemodial Int; 2013 Oct; 17(4):557-67. PubMed ID: 23627905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified citrate anticoagulation for high-flux hemodialysis.
    Apsner R; Buchmayer H; Lang T; Unver B; Speiser W; Sunder-Plassmann G; Hörl WH
    Am J Kidney Dis; 2001 Nov; 38(5):979-87. PubMed ID: 11684550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renal transplantation on endothelial function in haemodialysis patients.
    Kocak H; Ceken K; Yavuz A; Yucel S; Gurkan A; Erdogan O; Ersoy F; Yakupoglu G; Demirbas A; Tuncer M
    Nephrol Dial Transplant; 2006 Jan; 21(1):203-7. PubMed ID: 16144848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
    Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of oxidative stress before and after haemodialysis in chronic renal failure.
    Chugh SN; Jain S; Agrawal N; Sharma A
    J Assoc Physicians India; 2000 Oct; 48(10):981-4. PubMed ID: 11200923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the extracorporeal circuit in the trapping and degranulation of platelets.
    Gritters-van den Oever M; Schoorl M; Schoorl M; Bartels PC; Grooteman MP; Nubé MJ
    Blood Purif; 2009; 28(3):253-9. PubMed ID: 19684392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-tocopherol supplementation decreases electronegative low-density lipoprotein concentration [LDL(-)] in haemodialysis patients.
    Mafra D; Santos FR; Lobo JC; de Mattos Grosso D; Barreira AL; Velarde LG; Abdalla DS; Leite M
    Nephrol Dial Transplant; 2009 May; 24(5):1587-92. PubMed ID: 19176686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
    Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
    Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.